← Open Payments lookup

ERIN LADD: Open Payments

NPI 1962092502 · GOLDEN, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,527 in 66 payments from 15 companies in 2025. Trend: 2023 $58 · 2024 $335 · 2025 $1,527

Food & beverage: $1,527
CompanyPaymentsAmount
ABBVIE INC.18$403
Alkermes, Inc.8$375
Supernus Pharmaceuticals, Inc.11$233
Otsuka America Pharmaceutical, Inc.11$160
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$74
Collegium Pharmaceutical, Inc.2$41
Axsome Therapeutics, Inc.2$40
Indivior Inc.2$37
PFIZER INC.2$34
Vanda Pharmaceuticals Inc.2$32

Products named: VRAYLAR, Qelbree, ARISTADA, REXULTI, LYBALVI, CAPLYTA, VIVITROL, Jornay PM.

Industry payments across CO — which companies pay providers there.